Arcutis Biotherapeutics Inc (ARQT)
9.20
+0.08
(+0.88%)
USD |
NASDAQ |
May 17, 16:00
9.12
-0.08
(-0.87%)
After-Hours: 20:00
Arcutis Biotherapeutics Revenue (Quarterly): 49.57M for March 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 49.57M |
| December 31, 2023 | 13.53M |
| September 30, 2023 | 38.11M |
| June 30, 2023 | 5.19M |
| Date | Value |
|---|---|
| March 31, 2023 | 2.781M |
| December 31, 2022 | 2.961M |
| September 30, 2022 | 0.725M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.725M
Minimum
Sep 2022
49.57M
Maximum
Mar 2024
16.12M
Average
5.19M
Median
Jun 2023
Revenue (Quarterly) Benchmarks
| AdaptHealth Corp | 594.10M |
| Prestige Consumer Healthcare Inc | 276.99M |
| Pfizer Inc | 14.88B |
| Adverum Biotechnologies Inc | -- |
| Karuna Therapeutics Inc (DELISTED) | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -35.38M |
| Total Expenses (Quarterly) | 81.19M |
| EPS Diluted (Quarterly) | -0.32 |
| Enterprise Value | 863.97M |
| Gross Profit Margin (Quarterly) | 93.43% |
| Profit Margin (Quarterly) | -71.38% |
| Earnings Yield | -31.85% |
| Normalized Earnings Yield | -31.85 |